Notice of Intent to Grant Partially Exclusive License, 92858 [2016-30501]

Download as PDF 92858 Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices Agenda: The tentative agenda for the meeting of the Working Group on Presumptions includes: general comments on use of disease and exposure presumptions in compensation programs; current use of presumptions in EEOICP; expanding/ improving the use of presumptions in EEOICP; any new business as proposed by working group members. OWCP will transcribe the Advisory Board working group meeting. OWCP will post the transcripts on the Advisory Board Web page, http://www.dol.gov/ owcp/energy/regs/compliance/ AdvisoryBoard.htm, along with written comments and other materials submitted to the working group or presented at the working group meeting. mstockstill on DSK3G9T082PROD with NOTICES Public Participation, Submissions, and Access to the Public Record Working group meeting: The working group will meet via teleconference on Tuesday, January 10, 2017, from 1:00 p.m. to 3:30 p.m. Eastern Time. Advisory Board working group meetings are open to the public. The teleconference number and other details for listening to the meeting will be posted on the Advisory Board’s Web site no later than 72 hours prior to the meeting. This information will be posted at http://www.dol.gov/owcp/ energy/regs/compliance/ AdvisoryBoard.htm. Requests for special accommodations: Please submit requests for special accommodations to participate in the working group meeting by email, telephone, or hard copy to Ms. Carrie Rhoads, OWCP, Room S–3524, U.S. Department of Labor, 200 Constitution Avenue NW., Washington, DC 20210; telephone (202) 343–5580; email EnergyAdvisoryBoard@dol.gov. Submission of written comments for the record: You may submit written comments, identified by the working group name and the meeting date of January 10, 2017, by any of the following methods: • Electronically: Send to: EnergyAdvisoryBoard@dol.gov (specify in the email subject line, ‘‘Working Group on Presumptions’’). • Mail, express delivery, hand delivery, messenger, or courier service: Submit one copy to the following address: U.S. Department of Labor, Office of Workers’ Compensation Programs, Advisory Board on Toxic Substances and Worker Health, Room S–3522, 200 Constitution Ave. NW., Washington, DC 20210. Due to securityrelated procedures, receipt of submissions by regular mail may experience significant delays. VerDate Sep<11>2014 19:36 Dec 19, 2016 Jkt 241001 Comments must be received by January 3, 2017. OWCP will make available publically, without change, any written comments, including any personal information that you provide. Therefore, OWCP cautions interested parties against submitting personal information such as Social Security numbers and birthdates. Electronic copies of this Federal Register notice are available at http:// www.regulations.gov. This notice, as well as news releases and other relevant information, are also available on the Advisory Board’s Web page at http:// www.dol.gov/owcp/energy/regs/ compliance/AdvisoryBoard.htm. FOR FURTHER INFORMATION CONTACT: You may contact Antonio Rios, Designated Federal Officer, at rios.antonio@dol.gov, or Carrie Rhoads, Alternate Designated Federal Officer, at rhoads.carrie@ dol.gov, U.S. Department of Labor, 200 Constitution Avenue NW., Suite S– 3524, Washington, DC 20210, telephone (202) 343–5580. This is not a toll-free number. Signed at Washington, DC, this 14th day of December, 2016. Leonard J. Howie III, Director, Office of Workers’ Compensation Programs. [FR Doc. 2016–30516 Filed 12–19–16; 8:45 am] BILLING CODE 4510–24–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (16–089)] National Aeronautics and Space Administration. ACTION: Notice of Intent to Grant Partially Exclusive License. AGENCY: This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive, license in the United States to practice the inventions described and claimed in U.S. Patent No. 7,623,972 entitled ‘‘Detection of Presence of Chemical Precursors’’; U.S. Patent No. 7,801,687 entitled ‘‘Chemical Sensors Using Coated Or Doped Carbon Nanotube Networks’’; U.S. Patent No. 7,968,054 entitled ‘‘Nanostructure Sensing and Transmission of Gas Data’’; U.S. Patent No. 8,000,903 entitled ‘‘Coated or Doped Carbon Nanotube Network Sensors as Affected by Environmental Parameters’’; ARC– 16292–1 entitled ‘‘Nanosensor/Cell Phone Hybrid for Detecting Chemicals SUMMARY: Frm 00089 Fmt 4703 The prospective partially exclusive license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. DATES: Objections relating to the prospective license may be submitted to Patent Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 202A–4, Moffett Field, CA 94035–1000. (650) 604–5104; Fax (650) 604–2767. ADDRESSES: Notice of Intent to Grant Partially Exclusive License PO 00000 and Concentrations’’; ARC–16902–1, entitled ‘‘Nanosensor for Medical Diagnoses’’; ARC–17110–1 entitled ‘‘Detection of Gases and Vapors at Low Concentrations’’ to ENDO Medical Inc., having its principal place of business at 2345 Yale Street, 1st Floor, Palo Alto, CA 94306. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. Sfmt 9990 FOR FURTHER INFORMATION CONTACT: Robert M. Padilla, Chief Patent Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 202A–4, Moffett Field, CA 94035–1000. (650) 604–5104; Fax (650) 604–2767. Information about other NASA inventions available for licensing can be found online at http:// technology.nasa.gov/. Mark P. Dvorscak, Agency Counsel for Intellectual Property. [FR Doc. 2016–30501 Filed 12–19–16; 8:45 am] BILLING CODE 7510–13–P E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Page 92858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30501]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (16-089)]


Notice of Intent to Grant Partially Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Intent to Grant Partially Exclusive License.

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and 
37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant 
a partially exclusive, license in the United States to practice the 
inventions described and claimed in U.S. Patent No. 7,623,972 entitled 
``Detection of Presence of Chemical Precursors''; U.S. Patent No. 
7,801,687 entitled ``Chemical Sensors Using Coated Or Doped Carbon 
Nanotube Networks''; U.S. Patent No. 7,968,054 entitled ``Nanostructure 
Sensing and Transmission of Gas Data''; U.S. Patent No. 8,000,903 
entitled ``Coated or Doped Carbon Nanotube Network Sensors as Affected 
by Environmental Parameters''; ARC-16292-1 entitled ``Nanosensor/Cell 
Phone Hybrid for Detecting Chemicals and Concentrations''; ARC-16902-1, 
entitled ``Nanosensor for Medical Diagnoses''; ARC-17110-1 entitled 
``Detection of Gases and Vapors at Low Concentrations'' to ENDO Medical 
Inc., having its principal place of business at 2345 Yale Street, 1st 
Floor, Palo Alto, CA 94306. The patent rights in this invention have 
been assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. The 
prospective partially exclusive license will comply with the terms and 
conditions of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective partially exclusive license may be granted 
unless, within fifteen (15) days from the date of this published 
notice, NASA receives written objections including evidence and 
argument that establish that the grant of the license would not be 
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. 
Competing applications completed and received by NASA within fifteen 
(15) days of the date of this published notice will also be treated as 
objections to the grant of the contemplated partially exclusive 
license.
    Objections submitted in response to this notice will not be made 
available to the public for inspection and, to the extent permitted by 
law, will not be released under the Freedom of Information Act, 5 
U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, NASA Ames 
Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 
604-5104; Fax (650) 604-2767.

FOR FURTHER INFORMATION CONTACT: Robert M. Padilla, Chief Patent 
Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 
202A-4, Moffett Field, CA 94035-1000. (650) 604-5104; Fax (650) 604-
2767. Information about other NASA inventions available for licensing 
can be found online at http://technology.nasa.gov/.

Mark P. Dvorscak,
Agency Counsel for Intellectual Property.
[FR Doc. 2016-30501 Filed 12-19-16; 8:45 am]
 BILLING CODE 7510-13-P